Glucotrack (GCTK) EBITDA Margin (2014 - 2020)
Glucotrack (GCTK) recorded quarterly EBITDA Margin of 617525.77% in Q2 2020, down 1777.62% on a QoQ basis from 32888.68% in Q1 2020, and down 61671835.0% year-over-year from N/an in Q3 2019.
Glucotrack (GCTK) EBITDA Margin (2014 - 2020) Analysis & Trends
Glucotrack has disclosed EBITDA Margin across 7 years of filings, most recently posting 617525.77% for Q2 2020.
- Quarterly EBITDA Margin fell 61671835.0% year-over-year to 617525.77% in Q2 2020, while the trailing twelve-month figure through Sep 2020 was 6658.35% (up 969995.0% YoY) and the FY2019 annual result came in at 1709.62%, up 1702847.0% from the prior year.
- EBITDA Margin retreated to 617525.77% in Q2 2020, from 32888.68% in the prior quarter.
- Over five years, EBITDA Margin peaked at 9599.1% in Q4 2019 and troughed at 617525.77% in Q2 2020.
- A 5-year average of 45380.89% and a median of 2763.6% in 2019 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2018 — EBITDA Margin soared 1622378 bps — and 2020, when it plunged 61671835 bps.
- Tracing GCTK's EBITDA Margin over 5 years: stood at 892.92% in 2016, then jumped by 532 bps to 3861.38% in 2017, then tumbled by 428 bps to 12658.92% in 2018, then surged by 176 bps to 9599.1% in 2019, then sank by 6533 bps to 617525.77% in 2020.
- Business Quant data shows GCTK's EBITDA Margin at 617525.77% in Q2 2020, 32888.68% in Q1 2020, and 9599.1% in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 28.86% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 1.97% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 1.63% |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 34.92% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 20.96% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 4.04% |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -9.90% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 13.65% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 2.44% |
| 10 | Glucotrack | 4.26 | -7.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -617,525.77% |
| Mar 31, 2020 | -32,888.68% |
| Dec 31, 2019 | 9,599.10% |
| Sep 30, 2019 | -23,946.44% |
| Jun 30, 2019 | -807.42% |
| Mar 31, 2019 | -4,126.44% |
| Jun 30, 2018 | -12,658.92% |
| Mar 31, 2018 | 6,524.48% |
| Dec 31, 2017 | 3,861.38% |
| Sep 30, 2017 | -12,424.96% |
| Jun 30, 2017 | -28,882.71% |
| Mar 31, 2017 | 2,595.25% |
| Dec 31, 2016 | -892.92% |
| Sep 30, 2016 | -12,701.02% |
| Jun 30, 2016 | -418.37% |
| Mar 31, 2016 | -1,400.77% |
| Jun 30, 2015 | -2,330.53% |
| Mar 31, 2015 | -2,078.73% |
| Dec 31, 2014 | -2,380.65% |
| Sep 30, 2014 | -2,715.88% |